The significance of the 'dust-like particles' pattern of immunofluorescence. A study of 66 cases

British Journal of Dermatology

Volumn 138, Issue 6, 1998, Pages 1039-1042

  Lipsker, D ^a   Di Cesare, M P ^a   Cribier, B ^a   Grosshans, E ^a   Heid, E ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CONNECTIVE TISSUE DISEASE; DERMIS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SJOEGREN SYNDROME; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, CUTANEOUS; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN;

EID: 0031778786     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02275.x     Document Type: Article

References (16)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115: 1409-15.
2. Di Cesare MP, Lipsker D, Cribier B et al. Etude de 52 cas de lupus érythémateux subaigu. Ann Dermatol Venereol 1996; 123: 75-6.
3. David-Bajar KM. Subacute cutaneous lupus erythematosus. J Invest Dermatol 1993; 101: 2-8.
4. Nieboer C, Tak-Diamand Z, van Leeuwen-Wallau HE. Dust-like particles: a specific direct immunofluorescence pattern in subacute cutaneous lupus erythematosus. Br J Dermatol 1988; 118: 725-34.
5. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
6. Masi AT, Rodnan GP, Medsger TA et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-4.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-8.
8. Workshop on diagnosis criteria of Sjögren's syndrome. Clin Exp Rheumatol 1989; 7: 111-17.
9. Alarcon-Segovia D; Cardiel MH. Comparison between 3 diagnostic criteria for MCTD. Study of 593 patients. J Rheumatol 1989; 16: 528-33.
10. Burnham TK, Neblett TR, Fine G. The application of the fluorescent antibody technique to the investigation of lupus erythematosus and various dermatoses. J Invest Dermatol 1963; 41: 151-6.
11. Anderson I, Anderson P, Elling P et al. Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: correlation with ENA antibodies. Ann Rheum Dis 1983; 42: 163-7.
12. Prystowski SD, Tuffanelli DL. Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Arch Dermatol 1978; 114: 705-10.
13. David-Bajar KM, Bennion SD, DeSpain JD et al. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 1992; 99: 251-7.
14. Valeski JF, Kumar V, Forman AB et al. A characteristic cutaneous direct immunofluorescent pattern associated with Ro (SS-A) antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol 1992; 27: 194-8.
15. Lee L, Gaither KK, Coulter SN et al. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin grafted mice. J Clin Invest 1989; 83: 1556-62.
16. Provost TT, Levin LS, Watson RM et al. Detection of anti-Ro (SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome. J Autoimmunity 1991; 4: 87-96.